Mid-market private equity firm, Inflexion, has announced an investment in Pangaea Laboratories, a global beauty business and owner of the British skincare brand Medik8.
The investment was made by Inflexion Buyout Fund V, Inflexion’s dedicated mid-market fund.
Founder of Medik8, Elliot Isaacs, commented, “In the last three years, the brand has experienced phenomenal growth as the skincare consumer has become more knowledgeable and moved towards science and ingredients. We are thrilled to be partnering with Inflexion who have the passion and expertise to help us accelerate the brand’s international ambitions.”
Simon Turner, managing partner of Inflexion, said, “Medik8’s science-based approach to skincare combined with its sustainability credentials make it an incredibly impressive business. We look forward to working closely with the whole team to scale the business further through enhancing their digital routes to market, and by supporting their continued innovation, new product launches and international expansion.”
